Tumor Immunophenotyping‐Derived Signature Identifies Prognosis and Neoadjuvant Immunotherapeutic Responsiveness in Gastric Cancer

Abstract The effectiveness of neoadjuvant immune checkpoint inhibitor (ICI) therapy is confirmed in clinical trials; however, the patients suitable for receiving this therapy remain unspecified. Previous studies have demonstrated that the tumor microenvironment (TME) dominates immunotherapy; therefo...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Jia‐Bin Wang, Qing‐Zhu Qiu, Qiao‐Ling Zheng, Ya‐Jun Zhao, Yu Xu, Tao Zhang, Shuan‐Hu Wang, Quan Wang, Qin‐Wen Jin, Yin‐Hua Ye, Ping Li, Jian‐Wei Xie, Jian‐Xian Lin, Jun Lu, Qi‐Yue Chen, Long‐Long Cao, Ying‐Hong Yang, Chao‐Hui Zheng, Chang‐Ming Huang
Format:	Artigo
Sprog:	Inglês
Udgivet:	Wiley 2023-05-01
Serier:	Advanced Science
Fag:	gastric cancer immune contexture neoadjuvant immune checkpoint inhibitor therapy prognosis tumor microenvironment
Online adgang:	https://doi.org/10.1002/advs.202207417
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!